In line with the above, a recent study in patients with coronary heart disease (CHD) and depression found out that reduced cortisol bioavailability and attenuated glucocorticoid responsiveness due to decreased expression and sensitivity of GR may lead to insufficient glucocorticoid signaling and thus elevation of inflammation in these patients [61]. Here, NR3C1 is linked to major depressive disorder.